CORPORATE ACCESS

WINTER SPRINGS, Fla., March 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is...

Letter Notifying Customers of Potential Issues with MRidium 1057 MRI Syringe Adapter SetWINTER SPRINGS, Fla., Feb. 24, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a...

Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10.The Board of Directors approved a special...

WINTER SPRINGS, Fla., Jan. 26, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 fourth quarter financial results before the market opens on Thursday, February 2, 2023. IRADIMED management will host a conference call...

Reports preliminary fourth quarter 2022 revenue of $14.9 millionAnnounces full-year and first-quarter 2023 financial guidance WINTER SPRINGS, Fla., Jan. 18, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced selected preliminary financial...

Revenue was $13.4 million and increased by 23%Operating income was $4.1 million and increased 32%GAAP diluted EPS was $0.27 and increased by 35%Announces fourth quarter 2022 financial guidance WINTER SPRINGS, Fla., Nov. 03, 2022 -- IRADIMED CORPORATION (the "Company")...

WINTER SPRINGS, Fla., Oct. 27, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 third quarter financial results before the market opens on Thursday, November 3rd. IRADIMED management will host a conference call the...

Reports second quarter 2022 revenue of $12.7 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.26Announces third quarter 2022 financial guidance WINTER SPRINGS, Fla., July 29, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced today...

WINTER SPRINGS, Fla., July 28, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., July 22, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 second quarter financial results before the market opens on Friday, July 29th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., May 26, 2022 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced that John (Jack) Glenn has been appointed Chief Financial Officer effective on or before June 20, 2022. Mr. Glenn will assume responsibility for all areas of accounting and...

Reports first quarter 2022 revenue of $12.3 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.22Announces second quarter 2022 financial guidanceIncreases full-year 2022 financial guidance WINTER SPRINGS, Fla., April 29, 2022 -- IRADIMED CORPORATION...

WINTER SPRINGS, Fla., April 28, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced today announced that Chris Scott, Chief Financial and Operating Officer, has resigned from the Company effective May 27, 2022. Mr. Scott started at the Company in...

WINTER SPRINGS, Fla., April 05, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2022 first quarter financial results before the market opens on Friday, April 29th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., Feb. 07, 2022 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), announced that its Board of Directors approved a special cash dividend of $1.00 per share on the Company's outstanding common stock. This special cash dividend is payable on...

Reports fourth quarter 2021 revenue of $11.9 million, GAAP diluted EPS of $0.31 and non-GAAP diluted EPS of $0.33Announces full-year and first quarter 2022 financial guidance WINTER SPRINGS, Fla., Feb. 04, 2022 -- iRadimed Corporation (the "Company") (NASDAQ: IRMD), a...

WINTER SPRINGS, Fla., Jan. 20, 2022 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 fourth quarter financial results before the market opens on Friday, February 4th. IRADIMED management will host a conference call the same...

Reports third quarter 2021 revenue of $10.9 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Increases full-year 2021 financial guidance WINTER SPRINGS, Fla., Oct. 29, 2021 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in the...

WINTER SPRINGS, Fla., Oct. 08, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market opens on Friday, October 29th. IRADIMED management will host a conference call the same...

Reports second quarter 2021 revenue of $9.8 million, GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.14Issues Q3 and full year 2021 financial guidance WINTER SPRINGS, Fla., July 30, 2021 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), a leader in the...

WINTER SPRINGS, Fla., July 07, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market opens on Friday, July 30th. IRADIMED management will host a conference call the same...

Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13Reports combined cash and investments of $52.7 million as of March 31, 2021 WINTER SPRINGS, Fla., April 30, 2021 -- IRADIMED CORPORATION (the "Company")...

WINTER SPRINGS, Fla., April 09, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 first quarter financial results before the market opens on Friday, April 30th. IRADIMED management will host a conference call the same...

Reports fourth quarter 2020 revenue of $8.5 million, GAAP diluted EPS of $0.05 and non-GAAP diluted EPS of $0.07Reports combined cash and investments of $52.0 million as of December 31, 2020 WINTER SPRINGS, Fla., Feb. 04, 2021 -- IRADIMED CORPORATION (the "Company")...

WINTER SPRINGS, Fla., Jan. 27, 2021 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 fourth quarter financial results before the market opens on Thursday, February 4th. IRADIMED management will host a conference call the...

Reports third quarter 2020 revenue of $7.7 million, GAAP diluted EPS of $0.09 and non-GAAP diluted EPS of $0.11Reports combined cash and investments of $49.9 million as of September 30, 2020 WINTER SPRINGS, Fla., Oct. 30, 2020 -- iRadimed Corporation (the "Company")...

WINTER SPRINGS, Fla., Oct. 08, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 third quarter financial results before the market opens on Friday, October 30th. IRADIMED management will host a conference call the same...

Reports second quarter 2020 revenue of $6.8 million, GAAP diluted EPS of $(0.17) and non-GAAP diluted EPS of $0.05Reports combined cash and investments of $47.8 million as of June 30, 2020 WINTER SPRINGS, Fla., July 30, 2020 -- iRadimed Corporation (the "Company")...

WINTER SPRINGS, Fla., July 16, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the market opens on Thursday, July 30th. IRADIMED management will host a conference call the same...

WINTER SPRINGS, Fla., May 29, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD), announced today that its Board of Directors has appointed Roger Susi to resume his duties as the Company's President and Chief Executive Officer after the departure of Leslie McDonnell, who...

Latest patent expands previous claims around IRADIMED's wireless communication as used to remotely control an IV pumpWINTER SPRINGS, Fla., May 11, 2020 -- IRADIMED CORPORATION (NASDAQ:IRMD), today announced the issuance by the U.S. Patent and Trademark Office of a...

Reports first quarter 2020 revenue of $8.7 million, GAAP diluted EPS of $0.14 and non-GAAP diluted EPS of $0.18Reports combined cash and investments of $47.4 million as of March 31, 2020 WINTER SPRINGS, Fla., April 30, 2020 -- IRADIMED CORPORATION (the "Company")...

WINTER SPRINGS, Fla., April 16, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 first quarter financial results before the market opens on Thursday, April 30th. iRadimed management will host a conference call the same...

Expects first quarter 2020 revenue of $8.6 million to $8.7 millionWINTER SPRINGS, Fla., April 07, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced that it expects to report first quarter 2020 revenue of $8.6 million to $8.7 million and is withdrawing its first...

WINTER SPRINGS, Fla., March 12, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020. Mr. Neuhardt will report to Leslie McDonnell, President and Chief Executive...

WINTER SPRINGS, Fla., March 06, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) today announced that Leslie McDonnell, President and Chief Executive Officer, will present at the 32nd Annual Roth Conference in Laguna Niguel, CA. Ms. McDonnell is scheduled to present on...

WINTER SPRINGS, Fla., Feb. 26, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Francis Casey, Vice President of Regulatory Affairs and Quality Assurance, effective June 30, 2020 after leading the Company's regulatory efforts since 2004....

Reports fourth quarter 2019 revenue of $10.9 million, GAAP diluted EPS of $0.26 and non-GAAP diluted EPS of $0.30Renewed CE Mark for patient vital signs monitor and shipped associated backlog during the fourth quarter 2019Announces 2020 full year and first quarter...

WINTER SPRINGS, Fla., Jan. 22, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 fourth quarter financial results before the market opens on Thursday, February 6th. IRADIMED management will host a conference call the...

WINTER SPRINGS, Fla., Jan. 07, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the retirement of Brent Johnson, Executive Vice President of Worldwide Sales and Marketing, effective April 10, 2020 after leading the Company's commercial efforts since 2012....

Immediately resumes shipments of patient vital signs monitoring systems into all markets requiring CE Mark WINTER SPRINGS, Fla., Dec. 12, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging ("MRI") medical...

Reports third quarter 2019 revenue of $10.0 million, GAAP diluted EPS of $0.20 and non-GAAP diluted EPS of $0.23Updates full-year financial guidance WINTER SPRINGS, Fla., Oct. 30, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in the development of innovative...

WINTER SPRINGS, Fla., Oct. 16, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 third quarter financial results before the market opens on Wednesday, October 30th. IRADIMED management will host a conference call the...

WINTER SPRINGS, Fla., Oct. 08, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that it received a close-out letter from the U.S. Food and Drug Administration resolving all issues cited in the August 2014 warning letter. "The resolution of the warning...

WINTER SPRINGS, Fla., Aug. 27, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD), today announced that Leslie McDonnell, President and Chief Executive Officer, Roger Susi, Chairman and Chief Technology Officer and Chris Scott, Chief Financial Officer, will participate in...

Reports second quarter 2019 revenue of $9.2 millionReports second quarter 2019 GAAP diluted EPS of $0.17 and non-GAAP diluted EPS of $0.20Updates full year earnings guidance WINTER SPRINGS, Fla., July 30, 2019 -- iRadimed Corporation (NASDAQ: IRMD), a leader in the...

WINTER SPRINGS, Fla., July 29, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that its Board of Directors unanimously appointed Leslie McDonnell, to succeed Roger Susi as President and Chief Executive Officer. Mr. Susi will step down as President and CEO...

WINTER SPRINGS, Fla., July 16, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 second quarter financial results before the market opens on Tuesday, July 30th. iRadimed management will host a conference call the same...

Reports first quarter 2019 revenue of $8.4 millionReports first quarter 2019 GAAP diluted EPS of $0.15 and non-GAAP diluted EPS of $0.13 WINTER SPRINGS, Fla., April 30, 2019 -- iRadimed Corporation (NASDAQ: IRMD), a leader in the development of innovative magnetic...

WINTER SPRINGS, Fla., April 16, 2019 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2019 first quarter financial results before the market opens on Tuesday, April 30th. IRADIMED management will host a conference call the same...